Hi
with the new acrylamide legislation coming into force April 2018. EU 2017/2158.
I've got customers asking
'Has the risk of acrylamide been suitably risk assessed, findings documented and mitigation established where required'
Does anyone have a company statement or policy they want to share for ideas
Many thanks